FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Related Tags >> Phase III   FDA   Phase II   pharmaceuticals
Syndicate content

Parkinson's News

Most Popular Parkinson's Story

Acadia inks $395 million development deal

Acadia Pharmaceuticals will pocket $30 million upfront and stands to earn another $365 million in milestones from Biovail as they pursue an approval for a late-stage drug designed to treat... Read more...

Latest Headlines